Literature DB >> 11154268

Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene.

O Shi1, S M Morris, H Zoghbi, C W Porter, W E O'Brien.   

Abstract

Mammals express two isoforms of arginase, designated types I and II. Arginase I is a component of the urea cycle, and inherited defects in arginase I have deleterious consequences in humans. In contrast, the physiologic role of arginase II has not been defined, and no deficiencies in arginase II have been identified in humans. Mice with a disruption in the arginase II gene were created to investigate the role of this enzyme. Homozygous arginase II-deficient mice were viable and apparently indistinguishable from wild-type mice, except for an elevated plasma arginine level which indicates that arginase II plays an important role in arginine homeostasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11154268      PMCID: PMC86672          DOI: 10.1128/MCB.21.3.811-813.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  22 in total

1.  Metabolism of arginine in lactating rat mammary gland.

Authors:  V A Mezl; W E Knox
Journal:  Biochem J       Date:  1977-07-15       Impact factor: 3.857

2.  Cloning of rat liver arginase cDNA and elucidation of regulation of arginase gene expression in H4 rat hepatoma cells.

Authors:  G J Dizikes; E B Spector; S D Cederbaum
Journal:  Somat Cell Mol Genet       Date:  1986-07

3.  Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes.

Authors:  G J Dizikes; W W Grody; R M Kern; S D Cederbaum
Journal:  Biochem Biophys Res Commun       Date:  1986-11-26       Impact factor: 3.575

4.  Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver arginase.

Authors:  S Kawamoto; Y Amaya; K Murakami; F Tokunaga; S Iwanaga; K Kobayashi; T Saheki; S Kimura; M Mori
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

5.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.

Authors:  S L Mansour; K R Thomas; M R Capecchi
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

6.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain.

Authors:  A P McMahon; A Bradley
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

7.  Function of arginase in lactating mammary gland.

Authors:  M C Yip; W E Knox
Journal:  Biochem J       Date:  1972-05       Impact factor: 3.857

8.  Effect of major trauma on plasma free amino acid concentrations in geriatric patients.

Authors:  M Jeevanandam; D H Young; L Ramias; W R Schiller
Journal:  Am J Clin Nutr       Date:  1990-06       Impact factor: 7.045

9.  The utilization of ornithine and citrulline by the growing kitten.

Authors:  J G Morris; Q R Rogers; D L Winterrowd; E M Kamikawa
Journal:  J Nutr       Date:  1979-04       Impact factor: 4.798

10.  Ammonia intoxication in the near-adult cat as a result of a dietary deficiency of arginine.

Authors:  J G Morris; Q R Rogers
Journal:  Science       Date:  1978-01-27       Impact factor: 47.728

View more
  61 in total

1.  Enteral arginase II provides ornithine for citrulline synthesis.

Authors:  Juan C Marini; Bettina Keller; Inka Cajo Didelija; Leticia Castillo; Brendan Lee
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

Review 2.  Arginase: marker, effector, or candidate gene for asthma?

Authors:  Donata Vercelli
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

3.  Arginase II inhibition prevents nitrate tolerance.

Authors:  S M L Khong; K L Andrews; N N Huynh; K Venardos; A Aprico; D L Michell; M Zarei; K T Moe; G J Dusting; D M Kaye; J P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

Authors:  Alia Shatanawi; Maritza J Romero; Jennifer A Iddings; Surabhi Chandra; Nagavedi S Umapathy; Alexander D Verin; Ruth B Caldwell; R William Caldwell
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

Review 5.  Arginase: a critical regulator of nitric oxide synthesis and vascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-09       Impact factor: 2.557

Review 6.  Recent advances in arginine metabolism: roles and regulation of the arginases.

Authors:  Sidney M Morris
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

7.  Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failure.

Authors:  Vikram Sharma; Gabriella A M Ten Have; Lars Ytrebo; Sambit Sen; Christopher F Rose; R Neil Dalton; Charles Turner; Arthur Revhaug; Hans M H van-Eijk; Nicolaas E P Deutz; Rajiv Jalan; Rajeshwar P Mookerjee; Nathan A Davies
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

8.  Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation.

Authors:  Jinsam Chang; Shankar Thangamani; Myung H Kim; Benjamin Ulrich; Sidney M Morris; Chang H Kim
Journal:  Eur J Immunol       Date:  2013-02-14       Impact factor: 5.532

Review 9.  Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.

Authors:  Joseph E Qualls; Peter J Murray
Journal:  Semin Immunopathol       Date:  2015-10-21       Impact factor: 9.623

10.  Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.

Authors:  Aaron Erdely; Diane Kepka-Lenhart; Rebecca Salmen-Muniz; Rebecca Chapman; Tracy Hulderman; Michael Kashon; Petia P Simeonova; Sidney M Morris
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.